Heat-Labile Enterotoxins as Adjuvants or Anti-Inflammatory Agents
- 1 January 2010
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 39 (4-5) , 449-467
Abstract
Escherichia coli and Vibrio cholerae produce structurally related AB5-type heat-labile enterotoxins, which are classified into two major types. The Type I subfamily includes cholera toxin and E. coli LT-I, whereas the Type II subfamily comprises LT-IIa and LT‐IIb. In addition to their roles in microbial pathogenesis, the enterotoxins are widely and intensively studied for their exceptionally strong adjuvant and immunomodulatory activities, which are not necessarily dependent upon their abilities to elevate intracellular cAMP levels. Despite general structural similarities, these molecules, in intact or derivative form, display notable differences in their interactions with gangliosides or Toll-like receptors. This divergence results in differential immune response outcomes, the underlying mechanisms of which remain largely uncharacterized. Whereas the study of these molecules has been pivotal in understanding basic mechanisms of immune regulation, a formidable challenge is to dissociate toxicity from useful properties that can be exploited in vaccine development or for the treatment of autoimmune inflammatory diseases.Keywords
This publication has 79 references indexed in Scilit:
- In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coliVaccine, 2009
- Cholera toxin inhibits IL-12 production and CD8α+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 functionJournal of Experimental Medicine, 2009
- Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander AntigensPLOS ONE, 2009
- Mapping of a Microbial Protein Domain Involved in Binding and Activation of the TLR2/TLR1 HeterodimerThe Journal of Immunology, 2009
- Oral immunization: an updateCurrent Opinion in Gastroenterology, 2008
- Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by Type I and Type II heat-labile enterotoxinsExpert Review of Vaccines, 2007
- Targeting toll‐like receptors for drug development: a summary of commercial approachesImmunology & Cell Biology, 2007
- Toll-like receptor 2 signaling modulates the functions of CD4+CD25+regulatory T cellsProceedings of the National Academy of Sciences, 2006
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- α4 Integrins and L-selectin Differently Orchestrate T-cell Activity During Diabetes Prevention Following Oral Administration of CTB-insulinJournal of Autoimmunity, 2002